Time-dependent expression of cytochrome P450 genes in primary cultures of well-differentiated human hepatocytes

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 6, 1997, Pages 638-648

  George, Jacob ^a   Goodwin, Bryan ^a   Liddle, Christopher ^a   Tapner, Michael ^a   Farrell, Geoffrey C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031171612     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90199-2     Document Type: Article

References (48)

1. Combalbert J, Fabre I, Fabre G, Dalet I, Derancourt J, Cano JP, et al. Metabolism of cyclosporin A: IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of the P-450IIIA gene subfamily. Drug Metab Dispos 1989;17:197-207.
2. Pichard L, Fabre I, Fabre G, Domergue J, Saint Aubert B, Mourad G, et al. Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990;18:595-606.
3. Ashby J, Slykes JA. Does carcinogenic potency correlate with mutagenic potency in the Ames assay. Nature 1978;271: 452-5.
4. Berthou F, Ratanasavanh D, Alix D, Carlhant D, Riche C, Guillouzo A. Caffeine and theophylline metabolism in newborn and adult human hepatocytes: Comparison with adult rat hepatocytes. Biochem Pharmacol 1988;37:3691-700.
5. Veronese ME, McManus ME, Laupattarakasem P, Miners JO, Birkett DJ. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450. Drug Metab Dispos 1990;18:356-61.
6. Schuetz EG, Li D, Omiecinski CJ, Muller-Eberhard U, Kleinman HK, Elswick B, et al. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol 1988;134:309-23.
7. Saad B, Scholl FA, Thomas H, Schawalder H, Streit V, Waechter F, et al. Crude liver membrane fractions and extracellular matrix components as substrata regulate differentially the preservation and inducibility of cytochrome P-450 isoenzymes in cultured rat hepatocytes. Eur J Biochem 1993; 213:805-814.
8. Kocarek TA, Schuetz EG, Guzelian PS. Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel. Mol Pharmacol 1993;43:328-34.
9. Paine AJ. The maintenance of cytochrome P-450 in rat hepatocyte culture: Some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system. Chem Biol Interact 1990;74:1-31.
10. Wright MC, Paine AJ. Evidence that the loss of rat liver cytochrome P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell contacts and/or the absence of an extracellular matrix. Biochem Pharmacol 1992; 43:237-43.
11. Guillouzo A, Beaune P, Gascoin M-N, Begue J-M, Campion J-P, Guengerich FP, et al. Maintenance of cytochrome P-450 in cultured adult human hepatocytes. Biochem Pharmacol 1985;34:2991-5.
12. Blaauboer BJ, von Holsteijn I, van Graft M, Paine A. The concentration of cytochrome P-450 in human hepatocyte culture. Biochem Pharmacol 1985;34:2405-8.
13. Gomez-Lechon MJ, Lopez P, Donato T, Montoya A, Larrauri A, Gimenez P, et al. Culture of human hepatocytes from small surgical liver biopsies: Biochemical characterization and comparison with in vivo. In Vitro Cell Dev Biol Anim 1990;26:67-74.
14. Morel F, Beaune PH, Ratanasavanh D, Flinois J-P, Yang CS, Guengerich FP, et al. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur J Biochem 1990; 191:437-44.
15. Schuetz EG, Schuetz JD, Strom SC, Thompson MT, Fisher RA, Molowa DT, et al. Regulation of human liver cytochromes P-450 family 3A in primary and continuous culture of human hepatocytes. Hepatology 1993;18:1254-62.
16. Roberts EA, Xie ZW, Yang S, Lipa J. Inducibility of enzyme activities associated with the cytochrome P-450 1A family, ethoxyresorufin O-deeethylase, and methoxyresorufin O-demethylase in human hepatocyte lines derived from normal liver tissue. Drug Metab Dispos 1993;21:56-61.
17. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Canon FB, Laurie GW, et al. Basement membrane complexes with biological activity. Biochemistry 1986;25:312-8.
18. Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, et al. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 1992;6:752-8.
19. George J, Murray M, Byth K, Farrell GC. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995;21:120-8.
20. Strom SC, Jirtle RL, Jones RS, Novicki DL, Rosenberg MR, Novotny A, et al. Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst 1982;68:771-8.
21. Bissell DM, Guzelian PS. Phenotypic stability of adult rat hepatocytes in primary monolayer culture. Ann NY Acad Sci 1980;349:85-98.
22. Durnam DM, Palmiter RD. A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 1983;131:385-93.
23. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
24. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 1984; 12:7035-56.
25. Quattrochi LC, Pendurthi UR, Okino ST, Potenza C, Tukey RH. Human cytochrome P-450 4 mRNA and gene: Part of a multigene family that contains Alu sequences in its mRNA. Proc Natl Acad Sci USA 1986;83:6731-5.
26. Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA. Cloning and expression of complimentary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 1991;30:3247-55.
27. Song BJ, Gelboin HV, Park SS, Yang CS, Gonzalez FJ. Complementary DNA and protein sequences of ethanol-inducible rat and human P450s: Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem 1986;261: 16689-97.
28. Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwick JP, Meyer UA, et al. Human p450PCN1: Sequence, chromosomal localization, and direct evidence through cDNA expression that p450PCN1 is nifedipine oxidase. DNA 1988;7:79-86.
29. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, et al. Cytochrome P-450 hPCNS, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 1989;264:10388-95.
30. Komori M, Nishio K, Ohi H, Kitada M, Kamataki T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J Biochem 1989;105:161-3.
31. George J, Liddle C, Murray M, Byth K, Farrell GC. Pretranslational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem Pharmacol 1995;49: 873-81.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-5.
33. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
34. Leffert HL, Sell S. Alpha-fetoprotein biosynthesis during the growth cycle of differentiated fetal rat hepatocytes in primary monolayer culture. J Cell Biol 1974;61:823-9.
35. Liddle C, Mode A, Legraverend C, Gustafsson J-A. Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Arch Biochem Biophys 1992;298:159-66.
36. Morel F, Beaune P, Ratanasavanh D, Flinois J-P, Guengerich FP, Guillouzo A. Effects of various inducers on the expression of cytochromes P-450 IIC8, 9, 10 and IIIA in cultured adult human hepatocytes. Toxic in Vitro 1990;4:458-60.
37. Trautwein C, Davies M, Elias E, Strain A, Manns MP. Extracellular matrix proteins modulate cytochrome P450 2D6 expression in human hepatocytes. J Hepatol 1995;22:50-6.
38. Hayman EG, Pierschbacher MD, Ruoslahti E. Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol 1985;100:1948-54.
39. Iqbal S, Elcombe CR, Elias E. Maintenance of mixed-function oxidase and conjugation enzyme activities in hepatocyte cultures prepared from normal and diseased human liver. J Hepatol 1991;12:336-43.
40. Song BJ, Matsunaga T, Hardwick JP, Park SS, Veech RL, Gelboin HV, et al. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol Endocrinol 1987;1:542-7.
41. Eliasson E, Johansson I, Ingelman-Sundberg M. Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation. Proc Natl Acad Sci USA 1990;87:3225-9.
42. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992;22: 1-21.
43. Gonzalez FJ. Cytcohrome P450: problems and prospects. Trends Pharmacol Sci 1992;13:346-52.
44. Shaw PM, Barnes TS, Cameron D, Engeset J, Melvin WT, Omar G, et al. Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism. Biochem J 1989;263:653-63.
45. Guengerich FP. Polymorphism of cytochrome P450 in humans. Trends Pharmacol Sci 1989;10:107-9.
46. Christians U, Sewing KF. Cyclosporin metabolism in transplant patients. Pharmacol Ther 1993;57:291-345.
47. Paine AJ, Villa P. Ligands maintain cytochrome P-450 in liver cell culture by affecting its synthesis and degradation. Biochem Biophys Res Commun 1980;97:744-50.
48. Newman SL, Barwick JL, Elshourbagy NA, Guzelian PS. Measurement of the metabolism of cytochrome P-450 in cultured hepatocytes by a quantitative and specific immunochemical method. Biochem J 1982;204:281-90.